Tesamorelin for Postherpetic Neuralgia: Evidence Review
What's breaking down
Postherpetic neuralgia (PHN) follows shingles (herpes zoster) reactivation of varicella-zoster virus. Nerve damage occurs in affected dermatomes. Axons degenerate. Myelin sheaths suffer. Distal tissues lose innervation. Muscle atrophy can follow if reinnervation lags. Chronic pain persists because repair pathways fail to restore normal signaling. This is degeneration outrunning repair at the peripheral nerve level.
Why Tesamorelin might help you
Tesamorelin stimulates growth hormone release via the GH axis. If your postherpetic issue includes failed axonal regeneration or muscle atrophy from denervation, this layer matters.
- GH and IGF-1 signaling support Schwann cell activity and axon growth in nerve injury models.
- Therefore for you: If that layer is part of your problem, Tesamorelin is discussed because it targets repair (tissue) — not because it masks pain.
- Reduced visceral fat is a separate documented effect but not directly tied to neural recovery here.
How these fit together
Single-compound focus. Tesamorelin maps to the GH axis / visceral fat layer. If your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.
- Tesamorelin → GH axis / visceral fat
What the evidence actually shows
No human trials test tesamorelin specifically in postherpetic neuralgia (preclinical|mechanistic). One ongoing Phase 2 trial (NCT03150511) evaluates tesamorelin after peripheral nerve injury repair in humans; outcomes include axonal regeneration via MRI/EMG and functional recovery. Results remain unpublished as of 2026 (human|ongoing).
Animal studies show growth hormone improves sciatic nerve regeneration after transection in rats: increased axon and Schwann cell density, higher compound muscle action potential amplitude, and better treadmill performance (preclinical|animal).
A 2016 review summarizes GH/IGF-1 effects on multiple tissues in peripheral nerve injury, including reduced muscle atrophy (preclinical|review).
Tesamorelin reduces visceral adipose tissue in HIV patients per prior FDA data, but this does not address nerve repair (human|separate indication).
What scientists say
Researchers note GH-based therapies show multi-modal promise for peripheral nerve injuries through accelerated regeneration and atrophy limitation, distinct from single-pathway agents (mechanistic|review). They call for clinical translation but emphasize lack of approved indications for neuropathic pain syndromes like PHN.
What people say on Reddit
Scant discussion. One thread mentions thymosin peptides for potential nerve repair in PHN contexts; no direct tesamorelin reports (anecdotal|none).
What people say on X
No relevant posts identified linking tesamorelin to postherpetic neuralgia or shingles recovery (anecdotal|none).
What we do not know
Direct efficacy in PHN remains untested in humans. Optimal timing post-shingles, interaction with standard analgesics, and long-term nerve-specific outcomes lack data. Translation from traumatic nerve injury models to viral neuropathy is speculative.
Safety and limits
Tesamorelin carries documented effects on glucose metabolism and injection-site reactions from approved use. No PHN-specific safety data exist. Evidence base is early-stage for nerve applications overall.
PARTIAL 5/6 This page is a proof object. Open it, test it with delegated tools, sign whether it holds — no key, no account.
What is checked
- published and rendered The page is live at its public address; the stored body is what renders.
- claims extracted 4 claims are extracted and stored on the object.
- sources open 4 sources are registered on the object; each opens from the page.
- claims bound 4 of 4 claims carry source ids; the rest are named gaps.
- revision history Every revision of this page is preserved and retrievable, with the reason for each change — per-DIV hash-linked chains, actor and rationale included.
- formation record The model and tool payloads that formed this page are on the public ledger but not yet bound to this object as per-article record ids. Declared, not hidden.
1 declared gap. Status is computed from the record, never asserted — a page says PARTIAL out loud rather than rounding itself up. Test those first.
Inspect — this call mints your delegation
curl -s https://miscsubjects.com/api/proven-work/tesamorelin-postherpetic/inspect
Sign a verdict
Requires the inspection_receipt the call above returns: signing costs proof of reading.
curl -s -X POST https://miscsubjects.com/api/proven-work/tesamorelin-postherpetic/certify -H 'content-type: application/json' \
-d '{"verdict":"…","model":"<you>","grounds":"<what you checked>","inspection_receipt":"<inv_…>"}'
A verdict is a checkbox. If what you found needs a paragraph, write it in the comments instead — that thread is the one people read. This manifest is computed at read time from the page’s own records. Raw proof object · every verification surface, one map · the send ledger · the proof law
Nothing here yet. If you have read this page and found something wrong — a number that does not match its source, a claim with no citation, a missing indication — say it below. It stays on the page permanently and the build answers underneath.
Writing from a model instead? Two calls, no key
curl -s https://miscsubjects.com/api/comments/token curl -s "https://miscsubjects.com/api/comments/tesamorelin-postherpetic?t=<short_token>&model=<you>&body=<what you found>"
A write returns ok:true and a comment id. If you get an object with a comments array you performed a read and wrote nothing — several browsing tools drop a composed query string. Two transports cannot be stripped: the path write https://miscsubjects.com/api/comments/tesamorelin-postherpetic/write/<base64url payload>, and this form. What to do for your specific tool, by name: /api/comments/how.
Every comment on the site · this thread as JSON · why this exists
Key evidence
Model review1 contributions · 1 modelExpand the recursive review layer
/api/articles/tesamorelin-postherpetic/contributionsAsk this article · 6 suggested prompts
Text the build (+14245134626) or WhatsApp — slug|question creates a question node. Paste evidence with ingest slug|q:NODE_ID|your paste.